Search Results - E. A. Shmidt

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    DYNAMICS OF CYTOKINE LEVELS IN THE HOSPITALIZED PATIENTS WITH DIFFERENT CLINICAL TYPES OF ACUTE CORONARY SYNDROME by S. A. Berns, E. S. Kiprina, E. A. Shmidt, A. V. Veremeev, O. L. Barbarash

    Published 2016-04-01

    The study included 120 patients with acute coronary syndrome (ACS), which were divided: in two groups, respectively, with ACS-ST segment elevation (group 1, n = 80), and without this clinical sign (group 2, n = 40). The levels of interleukins (IL)-6, -8, -10, and tumor necrosis factor-α (TNFα) were...

    Full description

    Get full text
    Article
  2. 2

    SIRENA score for in-hospital mortality risk assessment in patients with acute pulmonary embolism by A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Shmidt, D. V. Duplyakov

    Published 2021-01-01

    Aim. To create a new prognostic scale for in-hospital mortality risk assessment in patients with pulmonary embolism (PE).Material and methods. The study was carried out on the basis of Russian register of acute pulmonary embolism SIRENA.Results. Based on the Russian register of acute pulmonary embol...

    Full description

    Get full text
    Article
  3. 3

    Coagulation status in patients with pulmonary embolism receiving long-term anticoagulant therapy by E. A. Shmidt, S. A. Berns, T. Yu. Penskaya, I. I. Zhidkova, O. V. Gruzdeva, O. L. Barbarash

    Published 2022-01-01

    Aim. To study the blood coagulation status by various laboratory methods in patients after pulmonary embolism (PE) receiving long-term anticoagulant therapy.Material and methods. The blood of 23 patients with pulmonary embolism, who received long-term anticoagulant therapy, was studied. The study of...

    Full description

    Get full text
    Article
  4. 4

    Long-term anticoagulant therapy in the aspect of secondary prevention of recurrent pulmonary embolism by E. A. Shmidt, T. Yu. Penskaya, O. V. Gruzdeva, S. A. Berns, V. N. Karetnikova, O. L. Barbarash

    Published 2024-06-01

    Aim. To determine differences in laboratory coagulation parameters using routine and integral monitoring methods in patients depending on anticoagulant therapy >12 months after pulmonary embolism (PE) with a high recurrence risk.Material and methods. The study included 72 patients who, accord...

    Full description

    Get full text
    Article
  5. 5

    Incidence and prognostic value of acute kidney injury in pulmonary embolism: data from the SIRENA registry by M. V. Menzorov, V. V. Filimonova, A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Shmidt, D. V. Duplyakov

    Published 2022-03-01

    Aim. To evaluate the incidence and severity of acute kidney injury (AKI), as well as its ability to reclassify the risk of premature mortality and association with inhospital mortality in patients with pulmonary embolism (PE) in the Russian population.Material and methods. From April 2018 to April 2...

    Full description

    Get full text
    Article
  6. 6

    Renal dysfunction in patients with pulmonary embolism: data from the SIRENA register by M. V. Menzorov, V. V. Filimonova, A. D. Erlikh, O. L. Barbarash, S. A. Berns, E. A. Shmidt, D. V. Duplyakov

    Published 2021-07-01

    Aim. To assess the prevalence, severity and prognostic value of renal dysfunction (RD) in patients with pulmonary embolism (PE) of the Russian population, as well as to determine the RD significance as a marker that improves the predictive ability of current risk stratification systems.Material and...

    Full description

    Get full text
    Article
  7. 7

    Russian register of acute pulmonary embolism SIRENA: characteristics of patients and in-hospital treatment by A. D. Erlikh, A. N. Atakanova, A. G. Neeshpapa, N. A. Cherepanova, I. S. Mullova, O. L. Barbarash, S. A. Berns, E. A. Shmidt, D. V. Duplyakov

    Published 2020-11-01

    Aim. To assess the features of diagnosis, treatment and outcomes of pulmonary embolism (PE) in patients of Russian hospitals.Material and methods. The register included all hospitalized patients with PE identified by any diagnostic method. Duration of inclusion was 12 months. In-hospital period mana...

    Full description

    Get full text
    Article
  8. 8

    ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION by E. A. Shmidt, S. A. Berns, I. I. Zhidkova, O. A. Makeeva, I. A. Goncharova, O. A. Nagirnyak, A. V. Klimenkova, M. N. Litvinova, O. L. Barbarash

    Published 2018-01-01

    Lymphotoxin-α (LTA) is a major pro-inflammatory cytokine produced at the early stages of vascular inflammation, taking part in the formation of arterial atherosclerosis and development of coronary heart disease. Functional changes in the gene encoding LTA production may influence the development of...

    Full description

    Get full text
    Article
  9. 9

    Features of in-hospital clinical course of pulmonary embolism in patients of different age groups by E. A. Shmidt, S. A. Berns, A. G. Neeshpapa, P. A. Talyzin, I. I. Zhidkova, I. N. Mamchur, A. A. Potapenko, D. A. Chukalenko, O. L. Barbarash

    Published 2020-11-01

    Aim. To study the clinical course and management of patients with pulmonary embolism (PE) of various age groups hospitalized in a cardiology hospital.Material and methods. This prospective single-center study in the period from 2016 to 2018 included 154 patients with PE verified by computed tomograp...

    Full description

    Get full text
    Article